CK Life Sciences Reports No Share Capital Changes in May 2026 Monthly Return

Bulletin Express

Jun 02

CK Life Sciences Int'l. (Holdings) Inc. filed its monthly return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 02 June 2026.

The company’s authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 1.50 billion.

Issued share capital was steady at 9.61 billion ordinary shares, and the issuer held no treasury shares. Consequently, the total number of issued shares (excluding treasury shares) also remained at 9.61 billion.

CK Life Sciences confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent as of 31 May 2026.

The company reported no activity under share option schemes, warrants, convertible instruments, or other agreements that could result in future share issuances during the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1125463807"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125463807\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125463807?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125463807","market":"us","top_or_hot":-1,"title":"CK Life Sciences Reports No Share Capital Changes in May 2026 Monthly Return","media":"Bulletin Express","content":"<p>CK Life Sciences Int'l. (Holdings) Inc. filed its monthly return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 02 June 2026.</p>\n<p>The company’s authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 1.50 billion.</p>\n<p>Issued share capital was steady at 9.61 billion ordinary shares, and the issuer held no treasury shares. Consequently, the total number of issued shares (excluding treasury shares) also remained at 9.61 billion.</p>\n<p>CK Life Sciences confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent as of 31 May 2026.</p>\n<p>The company reported no activity under share option schemes, warrants, convertible instruments, or other agreements that could result in future share issuances during the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CK Life Sciences Reports No Share Capital Changes in May 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCK Life Sciences Reports No Share Capital Changes in May 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-02 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CK Life Sciences Int'l. (Holdings) Inc. filed its monthly return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 02 June 2026.</p>\n<p>The company’s authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 1.50 billion.</p>\n<p>Issued share capital was steady at 9.61 billion ordinary shares, and the issuer held no treasury shares. Consequently, the total number of issued shares (excluding treasury shares) also remained at 9.61 billion.</p>\n<p>CK Life Sciences confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent as of 31 May 2026.</p>\n<p>The company reported no activity under share option schemes, warrants, convertible instruments, or other agreements that could result in future share issuances during the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00775","symbol_name":"长江生命科技","start_time":0,"source_url":"","article_id":"1125463807","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125463807","pubTimestamp":1780389933,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CK Life Sciences Int'l. (Holdings) Inc. filed its monthly return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00775":"长江生命科技"},"translate_title":"长江生命科学2026年5月股本无变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00775":1},"content_text":"CK Life Sciences Int'l. (Holdings) Inc. filed its monthly return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month. The filing was submitted to Hong Kong Exchanges and Clearing Limited on 02 June 2026.\nThe company’s authorised share capital stood at 15.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 1.50 billion.\nIssued share capital was steady at 9.61 billion ordinary shares, and the issuer held no treasury shares. Consequently, the total number of issued shares (excluding treasury shares) also remained at 9.61 billion.\nCK Life Sciences confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent as of 31 May 2026.\nThe company reported no activity under share option schemes, warrants, convertible instruments, or other agreements that could result in future share issuances during the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}